Pete A. Meyers - Net Worth and Insider Trading
Pete A. Meyers Net Worth
The estimated net worth of Pete A. Meyers is at least $2,597 dollars as of 2024-06-08. Pete A. Meyers is the CFO of Eagle Pharmaceuticals Inc and owns about 700 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $2,597. Details can be seen in Pete A. Meyers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pete A. Meyers has not made any transactions after 2017-08-16 and currently still holds the listed stock(s).
Transaction Summary of Pete A. Meyers
Pete A. Meyers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pete A. Meyers owns 2 companies in total, including Eagle Pharmaceuticals Inc (EGRX) , and TetraLogic Pharmaceuticals Corp (TLOG) .
Click here to see the complete history of Pete A. Meyers’s form 4 insider trades.
Insider Ownership Summary of Pete A. Meyers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2017-08-16 | Chief Financial Officer |
| TLOG | TetraLogic Pharmaceuticals Corp | 2015-03-27 | CFO & Treasurer |
Pete A. Meyers Latest Holdings Summary
Pete A. Meyers currently owns a total of 1 stock. Pete A. Meyers owns 700 shares of Eagle Pharmaceuticals Inc (EGRX) as of August 16, 2017, with a value of $2,597.
Latest Holdings of Pete A. Meyers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2017-08-16 | 700 | 3.71 | 2,597 |
Holding Weightings of Pete A. Meyers
Pete A. Meyers Form 4 Trading Tracker
According to the SEC Form 4 filings, Pete A. Meyers has made a total of 0 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years. The most-recent trade in Eagle Pharmaceuticals Inc is the acquisition of 350 shares on August 16, 2017, which cost Pete A. Meyers around $19,408.
Insider Trading History of Pete A. Meyers
- 1
Pete A. Meyers Trading Performance
GuruFocus tracks the stock performance after each of Pete A. Meyers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pete A. Meyers is -5.36%. GuruFocus also compares Pete A. Meyers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pete A. Meyers within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pete A. Meyers's insider trading performs compared to the benchmark.
Performance of Pete A. Meyers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.38 | | | | | |
| Relative Return to S&P 500(%) | 8.44 | | | | | |
Pete A. Meyers Ownership Network
Pete A. Meyers Owned Company Details
What does Eagle Pharmaceuticals Inc do?
Who are the key executives at Eagle Pharmaceuticals Inc?
Pete A. Meyers is the Chief Financial Officer of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include director & President and CEO Scott Tarriff , EVP & Chief Commercial Officer Michael Shawn Moran , and Chief Medical Officer Judith Ng-cashin .
Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary
Over the past 18 months, Pete A. Meyers made no insider transaction in Eagle Pharmaceuticals Inc (EGRX). Other recent insider transactions involving Eagle Pharmaceuticals Inc (EGRX) include a net sale of 101,864 shares made by Scott Tarriff ,
In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 101,864 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 101,864 shares.
Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eagle Pharmaceuticals Inc Insider Transactions
Pete A. Meyers Mailing Address
Above is the net worth, insider trading, and ownership report for Pete A. Meyers. You might contact Pete A. Meyers via mailing address: C/o Tetralogic Pharmaceuticals Corp, 343 Phoenixville Pike, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
